{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:52:35Z","timestamp":1792785155622,"version":"4.5.0"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","funder":[{"name":"Japan Research Foundation for Clinical\n                        Pharmacology"},{"name":"Japan Society for the Promotion of Science\n                        KAKENHI","award":["JP22K15755"],"award-info":[{"award-number":["JP22K15755"]}]},{"name":"Takeda Science\n                        Foundation."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study investigated the antisuicidal effects of repeated intravenous\n                        ketamine in patients with treatment-resistant depression and explored\n                        associations between suicidal ideation and temporal changes in selected\n                        plasma biomarkers to identify potential biomarkers.<\/jats:p>\n                  <jats:p>This secondary analysis of an open-label trial included outpatients with\n                        treatment-resistant depression who received four intravenous ketamine\n                        infusions (0.5 mg\/kg) over 2 weeks. Suicidal ideation was assessed at\n                        baseline and post-intervention using the Montgomery\u2013\u00c5sberg Depression Rating\n                        Scale (item 10), Quick Inventory of Depressive Symptomatology\u2013Self Report\n                        (item 12), and Columbia Suicide Severity Rating Scale. Eleven targeted\n                        plasma biomarkers were quantified via liquid chromatography\u2013mass\n                        spectrometry. Associations between suicidal ideation scores and biomarker\n                        changes were evaluated using Pearson\u2019s and Spearman\u2019s correlation\n                        coefficients, with p-values adjusted for multiple comparisons using\n                        the false discovery rate procedure.<\/jats:p>\n                  <jats:p>Repeated ketamine infusions were associated with modest reductions in\n                        suicide-related item scores on the Montgomery\u2013\u00c5sberg Depression Rating Scale\n                        item 10 (1.5\u00b11.5 to 1.0\u00b11.3, p=0.01) and Quick Inventory of\n                        Depressive Symptomatology\u2013Self Report item 12 (1.3\u00b10.9 to 0.8\u00b10.9,\n                        p=0.01). Columbia Suicide Severity Rating Scale scores numerically\n                        decreased (1.1\u00b11.3 to 0.8\u00b11.2, p=0.17) without reaching statistical\n                        significance. In unadjusted analyses, improved Columbia Suicide Severity\n                        Rating Scale scores showed nominal associations with increased levels of\n                        citric acid (r=\u2212\u20090.40, p=0.03) and kynurenic acid\n                        (\u03c1=\u2212\u20090.37, p=0.04), although these did not survive false\n                        discovery rate correction.<\/jats:p>\n                  <jats:p>Repeated ketamine infusions were associated with modest reductions in\n                        suicide-related item scores on the Montgomery\u2013\u00c5sberg Depression Rating Scale\n                        and Quick Inventory of Depressive Symptomatology\u2013Self Report. While no\n                        definitive biomarkers were identified after false discovery rate correction,\n                        these nominal associations are purely hypothesis-generating and require\n                        larger validation trials.<\/jats:p>","DOI":"10.1055\/a-2959-4626","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:46:51Z","timestamp":1790981211000},"source":"Crossref","is-referenced-by-count":0,"title":["Effects of Repeated Ketamine Infusions on Suicidal Ideation in\n                    Treatment-Resistant Depression and Associated Changes in Selected Plasma\n                    Biomarkers"],"prefix":"10.1055","clinical-trial-number":[{"clinical-trial-number":"jrcts031210648","registry":"10.18810\/jrct"}],"author":[{"given":"Masami","family":"Murao","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Setoyama","sequence":"additional","affiliation":[{"name":"Hokkaido University Faculty of Medicine, Japan","place":["Hokkaido"],"department":["Division of Reverse-Translational Research on Mental Health Biomarkers\n                    and Imaging Technology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro A","family":"Kato","sequence":"additional","affiliation":[{"name":"Hokkaido University Graduate School of Medicine, Japan","place":["Hokkaido"],"department":["Department of Psychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisateru","family":"Tachimori","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine, Japan","place":["Tokyo"],"department":["Department of Health Policy and Management"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Tada","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Seki","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Japan","place":["Tokyo"],"department":["Department of Anesthesiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-7946","authenticated-orcid":false,"given":"Hitoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Kyorin University School of Medicine, Tokyo, Japan","place":["Tokyo"],"department":["Department of Neuropsychiatry"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"15","key":"ref1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jama.2017.3826","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"M J Friedrich","year":"2017","journal-title":"JAMA"},{"issue":"16","key":"ref2","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1001\/jama.294.16.2064","article-title":"Suicide prevention strategies: a systematic review","volume":"294","author":"J J Mann","year":"2005","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as\n                    adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"M Fava","year":"2020","journal-title":"Mol Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jad.2020.07.089","article-title":"Long-term outcome in outpatients with depression treated with acute and\n                    maintenance intravenous ketamine: a retrospective chart review","volume":"276","author":"H Sakurai","year":"2020","journal-title":"J Affect Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a\n                    systematic review & meta-analysis","volume":"151","author":"Y Alnefeesi","year":"2022","journal-title":"J Psychiatr Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e067194","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind,\n                    randomised placebo controlled trial","volume":"376","author":"M Abbar","year":"2022","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jad.2021.12.055","article-title":"Ketamine vs midazolam: mood improvement reduces suicidal ideation in\n                    depression","volume":"300","author":"A Hochschild","year":"2022","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"ref9","doi-asserted-by":"publisher","first-page":"e0165267","DOI":"10.1371\/journal.pone.0165267","article-title":"Plasma metabolites predict severity of depression and suicidal ideation in\n                    psychiatric patients: a multicenter pilot analysis","volume":"11","author":"D Setoyama","year":"2016","journal-title":"PLoS One"},{"issue":"09","key":"ref10","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: a\n                    systematic review and meta-analysis","volume":"27","author":"G C Medeiros","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/pcn.13870","article-title":"Acute and long-term effects of repeated ketamine infusions in\n                    treatment-resistant depression and associated metabolite changes","volume":"79","author":"H Sakurai","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"S A Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"12","key":"ref13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The columbia\u2013suicide severity rating scale: initial validity and internal\n                    consistency findings from three multisite studies with adolescents and\n                    adults","volume":"168","author":"K Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"05","key":"ref14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(03)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician\n                    rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in\n                    patients with chronic major depression","volume":"54","author":"A J Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jad.2018.01.014","article-title":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for\n                    first-episode drug-na\u00efve patients with major depressive disorder: an exploratory\n                    pilot case-control study","volume":"231","author":"N Kuwano","year":"2018","journal-title":"J Affect Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jad.2020.09.118","article-title":"Personality classification enhances blood metabolome analysis and biotyping for\n                    major depressive disorders: two-species investigation","volume":"279","author":"D Setoyama","year":"2021","journal-title":"J Affect Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/wps.20705","article-title":"Defining pathological social withdrawal: proposed diagnostic criteria for\n                    hikikomori","volume":"19","author":"T A Kato","year":"2020","journal-title":"World Psychiatry"},{"issue":"02","key":"ref18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a\n                    systematic review and individual participant data meta-analysis","volume":"175","author":"S T Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in\n                    treatment-resistant depression","volume":"45","author":"J L Phillips","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"01","key":"ref20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"J Savitz","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"08","key":"ref21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/02698811211026426","article-title":"Ketamine\u2019s effect on inflammation and kynurenine pathway in depression: a\n                    systematic review","volume":"35","author":"E Kopra","year":"2021","journal-title":"J Psychopharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"106889","DOI":"10.1016\/j.bbi.2026.106889","article-title":"Kynurenine pathway profiles as markers of ketamine response in\n                    treatment-resistant depression","volume":"138","author":"B Pedraz-Petrozzi","year":"2026","journal-title":"Brain Behav Immun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e14576","DOI":"10.1111\/cns.14576","article-title":"Mitochondria in depression: the dysfunction of mitochondrial energy metabolism\n                    and quality control systems","volume":"30","author":"M Jiang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"15788","DOI":"10.1038\/s41598-017-16183-x","article-title":"Ketamine\u2019s antidepressant effect is mediated by energy metabolism and\n                    antioxidant defense system","volume":"7","author":"K Weckmann","year":"2017","journal-title":"Sci Rep"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2959-4626.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:46:52Z","timestamp":1790981212000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2959-4626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1055\/a-2959-4626","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}